|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-8-6
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Treatment guidelines recommend the use of peginterferon alfa-2b or peginterferon alfa-2a in combination with ribavirin for chronic hepatitis C virus (HCV) infection. However, these regimens have not been adequately compared.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:AlbrechtJanice KJK,
pubmed-author:BaconBruce RBR,
pubmed-author:BrassClifford ACA,
pubmed-author:DavisMitchell NMN,
pubmed-author:GalatiJoseph SJS,
pubmed-author:GallerGreg WGW,
pubmed-author:GhalibReem HRH,
pubmed-author:IDEAL Study Team,
pubmed-author:KouryKennethK,
pubmed-author:LawitzEric JEJ,
pubmed-author:LeeWilliam MWM,
pubmed-author:McConeJonathanJ,
pubmed-author:McHutchisonJohn GJG,
pubmed-author:MuirAndrew JAJ,
pubmed-author:MukhopadhyayPabakP,
pubmed-author:NovielloStephanieS,
pubmed-author:NybergLisa MLM,
pubmed-author:PediconeLisa DLD,
pubmed-author:SchiffEugene RER,
pubmed-author:ShiffmanMitchell LML,
pubmed-author:SulkowskiMark SMS
|
|
pubmed:copyrightInfo |
2009 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
6
|
|
pubmed:volume |
361
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
580-93
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19625712-Antiviral Agents,
pubmed-meshheading:19625712-Dose-Response Relationship, Drug,
pubmed-meshheading:19625712-Double-Blind Method,
pubmed-meshheading:19625712-Drug Therapy, Combination,
pubmed-meshheading:19625712-Female,
pubmed-meshheading:19625712-Genotype,
pubmed-meshheading:19625712-Hepacivirus,
pubmed-meshheading:19625712-Hepatitis C, Chronic,
pubmed-meshheading:19625712-Humans,
pubmed-meshheading:19625712-Interferon-alpha,
pubmed-meshheading:19625712-Male,
pubmed-meshheading:19625712-Middle Aged,
pubmed-meshheading:19625712-RNA, Viral,
pubmed-meshheading:19625712-Recombinant Proteins,
pubmed-meshheading:19625712-Ribavirin
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.
|
|
pubmed:affiliation |
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA. mchut001@mc.duke.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
